Back to Trades
Total Value
$2.0M
Net $2.0M sold
Filing Date
Jun 23, 2026
1 transaction
Sales
$2.0M
1 transaction
Trade Summary
On Jun 22, 2026, HENDERSON MICHAEL THOMAS, Director, sold $2.0M of Spyre Therapeutics, Inc. (SYRE) across 1 transaction. The filing covers Common Stock and reflects net selling of $2.0M. Reported prices ranged from $100.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Spyre Therapeutics, Inc.
- Ticker Symbol
- SYRE
- CIK
- 0001636282
Insider Information
- Role
- Director
- Location
- WALTHAM, MA
Filing Details
- Filing Date
- Jun 23, 2026
- Transaction Date
- Jun 22, 2026
- Accession Number
- 0001636282-26-000084
- Form Type
- 4
- Net Trading Amount
- -$2.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | 20,000 | $100.00 | Sale | $2.0M |
Want live alerts when HENDERSON MICHAEL THOMAS trades again?
Download Insider Trades to track SYRE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 6, 2026.